quidel.com - QDEL Company Value to Revenue Ratio

QuidelOrtho Corporation (QDEL) - corporate logo

QuidelOrtho specializes in laboratory diagnostics, generating revenue through long-term contracts for the supply of proprietary reagents for its analyzers. The EV/Sales valuation multiple demonstrates the business's resilience, with the value holding at 1374.36. Revenues depend on viral seasonality and equipment utilization, while production stability is ensured by a diversified network of vetted chemical component suppliers.

QuidelOrtho Inc. (QDEL): Enterprise Value-to-Revenue Ratio from 11/23/2025 to 11/20/2026

QDEL (QuidelOrtho Corp): analytical breakdowns and indicator data

- market price and analyst price targets:
Fundamental valuation:QuidelOrtho (QDEL)
Core merchandise of Quidel Corporation

Investors must filter out speculative volatility by evaluating the business value (EV) to revenue, excluding the impact of debt load, to determine the asset's fair price. Analyzing the EV/Sales trend reveals how the impeccable authority of QuidelOrtho (QDEL) in the rapid diagnostics sector supports the company's market value even amidst external shocks, confirming the high resilience and reliability of its fundamental metrics.

Competitor analysis for QuidelOrtho

A (Agilent) - Company Value to Revenue Ratio|DGX (Quest Diagnostics) - Company Value to Revenue|Illumina Inc (ILMN) - EV/Sales Multiple|Company Value to Revenue EXAS|Revvity, Inc. (RVTY) - Total Company Value-to-Revenue Ratio|EV/Sales Multiple BIO|NNNN (Anbio Biotechnology) - Business Value to Revenue|EV/Sales Multiple SHC (Sotera Health)|EV/Sales Multiple OPKO Health Inc OPK|CareDx Inc - EV/Sales Multiple|Business Value to Revenue MRVI (Maravai)|FLGT: EV/Sales Multiple|LAB (Standard BioTools Inc.) - Enterprise Value-to-Revenue Ratio|Enterprise Value-to-Revenue Ratio Cytek Biosciences Inc|Enterprise Value-to-Revenue Multiple OraSure OSUR|Company Value to Revenue XGN (Exagen Diagnostics)|Total Company Value-to-Revenue Ratio MDxHealth Inc.|Enterprise Value-to-Revenue Ratio Lucid Diagnostics, Inc. LUCD|Prenetics Global Ltd (PRE) - Enterprise Value-to-Revenue Multiple|Insight Molecular Diagnostics Inc - EV/Sales Multiple|Enterprise Value-to-Revenue Multiple trinitybiotech.com|PRPH (ProPhase) - Company Value to Revenue|Company Value to Revenue Ratio AIMD|Company Value to Revenue CODX|Enterprise Value-to-Revenue Multiple heartsciences.com HSCS|Enterprise Value-to-Revenue Ratio Biomerica Inc. (BMRA)|Total Company Value-to-Revenue Ratio Cardio Diagnostics Holdings|EV/Sales Multiple ONCO (Onconetix Corporation)|Virax Biolabs Group (VRAX) - Enterprise Value-to-Revenue Multiple|bluejaydx.com - EV/Sales Multiple|Aspira Women's Health - Enterprise Value-to-Revenue Coefficient|AXDX (Accelerate Diagnostics) - Company Value to Revenue|Company Value to Revenue CENTOGENE, N.V.|Enterprise Value-to-Revenue Ratio enzo.com|EV/Sales Multiple Fresh2 Group Limited|EV/Sales Multiple GENE|23andMe Holding Co. - Company Value to Revenue Ratio|Psychemedics Inc - Company Value to Revenue